Sie benötigen einen Webbrowser mit aktiviertem JavaScript um alle Features dieser Seite nutzen zu können.

NKF advises EFG Bank European Financial Group (Geneva) in the Euro 250 million Exchangeable Securities Offering

October 2009: On 1 October 2009 EFG Bank European Financial Group SA, Geneva (the “EFG Bank Group”) announced the issuanceby EFG Ora Funding Limited III (the “Issuer”) of €250 million senior unsecured bonds due 2014 (the “Bonds”) guaranteed by EFG Eurobank Ergasias S.A. (“Eurobank EFG”). The Bonds have attached, non-detachable exchangeable instruments issued by EFG Bank Group (together with the Bonds, the “Exchangeable Securities”). The Exchangeable Securities will be exchangeable into Eurobank EFG ordinary shares.

Niederer Kraft & Frey acted as Swiss counsel to EFG. The NKF team included Philippe Weber (lead, capital markets), Markus Kronauer (tax), Roger Föhn.

NKF advises Swiss Confederation in CHF 5.48 billion Placement of UBS Shares and CHF 1.8 billion MCN Coupon Redemption

August 2009: The Swiss Confederation has announced that Credit Suisse, Morgan Stanley and UBS have placed its UBS stake with institutional investors at a price of CHF 16.50 per UBS share. The total gross proceeds for the 332,2 million UBS shares sold by the Swiss Confederation, which resulted from conversion of the CHF 6 billion UBS Mandatory Convertible Notes (MCN) subscribed for by the Swiss Confederation in 2008, amount to approximately CHF 5.5 billion. In addition, UBS has paid the Swiss Confederation a cash amount of approximately CHF 1.8 billion in consideration for a waiver of future coupon payments under the MCN. Total net proceeds of the transaction, thus, amount to approximately CHF 7.2 billion. Niederer Kraft & Frey acted as legal adviser of the Swiss Confederation. The NKF team included Peter Forstmoser, Philippe Weber (Capital Markets), Markus Kronauer (Tax), Marco Häusermann and Philipp Candreia.

NKF advises SIX listed BB Medtech AG in friendly public exchange offer (Conversion into an equity fund)

July 2009: NKF acts for SIX listed BB Medtech in the public exchange offer of Vontobel Beteiligungen AG for BB Medtech AG, currently operating under the legal form of an investment company to change the company’s legal structure to an equity fund. NKF team: Philippe Weber, Thomas Graf (Tax), Roger Föhn, Gian-Andrea Caprez.

NKF underwriter counsel in CHF 30 million rights offering of Looser Holding

June / July, 2009: NKF underwriter counsel (Bank Sal. Oppenheim and Bank am Bellevue) in the CHF 30 million rights offering of SIX Swiss Exchange listed Looser Holding. NKF Team: Christoph Balsiger, Roger Föhn, Arie Gerszt

NKF issuer's counsel in CHF 420 m rights offering of Givaudan SA

June 2009: NKF issuer's counsel in the CHF 420 million rights offering of SIX Swiss Exchange listed, Geneva headquartered Givaudan SA, the world's leading creator and manufacturer of flavour and fragrance compounds. NKF Team: Peter Isler, Philipp Haas, Roger Föhn.

NKF advises Jelmoli Holding Ltd. in CHF 1.5 billion share exchange offer by SPS

June 2009: NKF advises SIX Swiss Exchange listed Jelmoli Holding Ltd. (target) in the >CHF 1.5 billion share exchange tender offer by Swiss Prime Site AG. NKF Team: Urs Pulver, Andreas Casutt, Philippe Weber, Philipp Haas, Patrik Peyer

NKF advises Creinvest AG (target) in an absorption merger between Julius Baer Invest Ltd and Creinvest Ltd.

June 2009: NKF advises SIX Swiss Exchange listed Creinvest AG (target) in an absorption merger between Julius Baer Invest Ltd and Creinvest Ltd (Andreas Casutt, Manuel Werder, Andrea Huber)

NKF advises Amber on Swiss Takeover Law in connection with public takeover of Harwanne

May 2009: NKF advises Amber Master Fund (Cayman) SPC ("Amber") on Swiss Takeover Law in connection with the public takeover offer of MMA Vie SA for Harwanne Compagnie de participations industrielles et financières SA. Amber successfully used the new minority shareholders rights in this public takeover (Philippe Weber, Gian-Andrea Caprez).

NKF advises SIX listed Esmertec on Swiss Takeover Law in connection with Acquisition of Purple Labs

February 2009: NKF advises SIX listed Esmertec AG on Swiss Takeover Law in connection with the acquisition of Purple Labs SA and creation of Myriad Group, Europe's leading Mobile Phone Software Company (Philippe Weber, Patrik Peyer)

NKF advises Newron Pharmaceuticals S.p.A. in CHF 30 m SEDA

November 2008: NKF Swiss counsel and listing agent for SIX Swiss Exchange listed company Newron Pharmaceuticals S.p.A. in a CHF 30 million standby equity distribution agreement (SEDA) with YA Global Investments, L.P. The SEDA provides Newron a long term standby equity line under which Newron has the option to take up YA Global's commitment to subscribe and pay for newly issued listed Newron shares to a total value of up to CHF 30 million over a period of 36 months at the discretion of Newron. (Philippe A. Weber and Andrea Huber)

NKF advises Swiss Confederation in the context of the transfer of currently illiquid securities with a value of up to USD 60 Billion.

October 2008: NKF Swiss counsel to the Swiss Confederation in transaction with UBS and Swiss National Bank regarding the transfer of up to USD 60 billion in currently illiquid securities and other assets from UBS's balance sheet to a separate special purpose vehicle. The transaction comprised a CHF 6 billion capital raising by UBS in the form of mandatory convertible notes fully placed with the Swiss Confederation. NKF team: Peter Forstmoser, Philippe A. Weber, Markus Kronauer (tax partner), Patrik Peyer and Eva Leuthold.

NKF advises Qatar Investment Authority (QIA) in CHF10 billion fund raising by Credit Suisse

October 2008: NKF advises Qatar Investment Authority (QIA) in CHF10 billion fund raising by Credit Suisse. The capital injection from a small group of investors consisted of three components: The sale of around 93 million treasury shares, the issuance of Mandatory Convertible Notes with a principal amount of CHF 1.6 billion, convertible into approximately 50 million new shares of Credit Suisse Group AG, and the issuance of hybrid Tier 1 Capital Notes in an amount of approximately CHF 5.5 billion. NKF acted for QIA (the biggest investor in this fund raising) along with White & Case and Schellenberg Wittmer. NKF team Philippe A. Weber, Andreas Casutt, Daniela Schmucki-Fricker (tax partner), Markus Kronauer (tax partner), Manuel Werder.

NKF advised IAWS Group plc and ARYZTA AG in the combination of IAWS' business with Hiestand Holding AG

August 2008: NKF advised IAWS Group plc and ARYZTA AG in the combination of IAWS' business with Hiestand Holding AG under the umbrella of ARYZTA AG as the new parent company and the listing of ARYZTA AG with a market cap of approx. CHF 4 billion at the SWX Swiss Exchange forming the global leader in value added baked goods with geographical reach extending from North America through Europe to South East Asia and Australia.
(Andreas Casutt, Philipp Haas, Olivier Bloch, Catherine Grun, Marco Häusermann, Andrea Huber, Dominic Studer)

NKF advises NLMK International BV in the acquisition of all shares in Novex Trading (Swiss) SA

May 2008: Novolipetsk Steel (NLMK, www.nlmksteel.com) is Russia's fourth-largest steel maker in terms of volume. NKF acted as Swiss legal advisor to NLMK International BV in the acquisition.
Transaction value (acquisition of Novex Trading (Swiss) SA and Novexco (Cyprus) Ltd.): EUR 77,105,000 (USD 120,191,000; CHF 125,840,000). (Adrian W. Kammerer, Nicolas Birkhäuser (anti trust regulation), Allegra Sosso)
Contact: Maria Starostina (NLMK; e-mail:maria@nlmk.nl)

NKF advises Bank am Bellevue on increase of share capital of HOCHDORF Holding AG

May 2008: NKF acts for Bank am Bellevue (Lead Manager) and other syndicate members in BX capital increase of gross CHF 37'800'000 of HOCHDORF Holding AG (Philippe A. Weber, Eva R. Leuthold)

NKF advises Desco von Schulthess Holding AG regarding sale of participations

March 2008: NKF advises Desco von Schulthess Holding AG regarding sale of Desco Rohstoffe Holding AG, Desco Asia Pacific Holding AG and a 19.9% participation in Maurice Lacroix Holding to DKSH Holding AG (Christian P.Meister, Ulysses von Salis, Christian Laux, Gian-Andrea Caprez)

NKF Legal Counsel of BSI (Generali Group) in the CHF 1,775 Billion Acquisition of Banca del Gottardo

November 2007: NKF Legal Counsel of BSI (Generali Group) in the CHF 1,775,000,000 acquisition of Banca del Gottardo (Philippe A. Weber, Urs Pulver, Adrian Kammerer, Andras A. Gurovits, Daniela Schmucki, Philipp Candreia)

NKF advises Credit Suisse in SWX IPO of u-blox Holding AG

October 2007: NKF acts for Credit Suisse (Global Coordinator) and other syndicate members in SWX IPO of u-blox Holding AG (Philippe A. Weber, Daniela Schmucki-Fricker (Tax), Patrik Peyer, Petra Ginter)

NKF Issuer Counsel in 2 Mia Thai IPO of Evason Hideaway at Yao Noi

27 July 2007: NKF acts together with Siam Premier International Law Office (Tawee Khositjiranum) as issuer counsel in Evason Hideaway at Yao Noi IPO in Thailand. Transaction volume: THB 2 billion (Markus A. Frey).

NKF advises in the SWX IPO of Newave Energy Holding SA

22 June 2007: NKF acts as issuer counsel in the SWX IPO of Newave Energy Holding SA (Philippe A. Weber, Daniela Schmucki-Fricker (taxes), Thomas M. Brönnimann, Andrea Huber)

NKF acts for Lehman Brothers in SWX IPO of Addex Pharmaceuticals SA

May 2007: NKF acts for Lehman Brothers (global co-ordinator) and other underwriters in SWX IPO of Addex Pharmaceuticals SA, Geneva (Philippe A. Weber, Daniela Schmucki-Fricker (taxes), Andrea Huber, Olivier Bloch).

NKF advises UBS in CHF 180 Mio SWX IPO of VZ Holding AG

March 2007: NKF has acted for UBS (Global Coordinator) and the other underwriters in the CHF 180 million Initial Public Offering and SWX listing of VZ Holding AG.
(NKF team: Philippe A. Weber, Sandro Abegglen , Daniela Schmucki-Fricker (taxes), Thomas M. Brönnimann)

NKF advises Morgan Stanley, Credit Suisse and UBS in CHF 324 Mio. Rights and Global Offering of Basilea Pharmaceutica AG

March 2007: NKF has acted for Morgan Stanley, Credit Suisse and UBS (Joint Global Coordinators) in the CHF 324,000,000 Rights and Global Offering of Basilea Pharmaceutica AG.
(NKF team: Philippe A. Weber, Philipp Haas , Petra Ginter)

NKF advises IsoTis regarding public exchange offer of ISOTIS/IsoTis regarding future listing of IsoTis on NASDAQ

December 2006: NKF advises IsoTis regarding public exchange offer of ISOTIS SA/IsoTis, Inc. in connection with move of registered office from Switzerland to US.
(NKF team: Philippe A. Weber, András A. Gurovits Kohli, Thomas Graf (taxes), Andrea Huber)

NKF advises tenders in USD 70 Mio. Credit Facility Agreement for SkyePharma

December 2006: NKF advises lenders regarding USD 70 million Credit Facility Agreement for SkyePharma arranged by Christofferson, Robb & Company.
(NKF team: Ulrich Benz, Markus E. Kronauer (taxes))

NKF advises Lehman Brothers and Morgan Stanley in CHF 120 Mio. IPO and SWX Listing of Newron Pharmaceuticals S.p.A.

December 2006: NKF has acted for Lehman Brothers and Morgan Stanley (Joint Global Coordinators) in the CHF 120 million Initial Public Offering and SWX Listing of Newron Pharmaceuticals S.p.A. (NKF team: Philippe A. Weber, Christoph Balsiger, Daniela Schmucki-Fricker, Andrea Huber)

NKF advises Horizon21 Private Equity Holding in the purchase of Swiss Re Private Equity Fund of Fund Advisory Business

November 2006: NKF advises purchaser regarding sale of Swiss Re's Private Equity Fund-of-Fund Advisory Business to Horizon21 Private Equity Holding.
(NKF team: Andreas Casutt, Daniela Schmucki-Fricker (taxes), Manuel Werder)

NKF advises Management in CHF 1.6 Billion Secondary Leveraged Buy-Out of SR Technics

November 2006: NKF advises management regarding CHF 1.6 billion secondary leveraged buy-out of SR Technics. (Philippe A. Weber and András A. Gurovits Kohli [M&A], Thomas Graf [taxes])

NKF advises Absolute US AG regarding public tender offer

November 2006: NKF advises Absolute US AG regarding public tender offer by Absolute US AG for all publicly held shares of Absolute Europe AG. (NKF team: Andreas Casutt and Philipp Haas)